NCT04532567View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GLPG1205 in Healthy Japanese and Caucasian Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 18, 2020

Primary Completion Date

December 10, 2020

Study Completion Date

December 10, 2020

Conditions
Healthy
Interventions
DRUG

GLPG1205

GLPG1205 film-coated tablets

DRUG

Placebo

placebo film-coated tablets

Trial Locations (1)

90630

WCCT Global, Cypress

Sponsors

Lead Sponsor

Galapagos NV
All Listed Sponsors
lead

Galapagos NV

INDUSTRY